SYnAbs, Belgium  

SYnAbs is a biotechnology company operating from Belgium with specialized expertise in complex and low-immunogenic targets. Its work focuses on generating monoclonal antibodies against transmembrane proteins, steroids, lipids, toxins, polysaccharides, and small molecules, using proprietary immunization strategies to achieve high specificity and affinity.